These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7166918)

  • 41. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
    Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
    Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urine cytology, tumour markers and bladder cancer.
    Halachmi S; Linn JF; Amiel GE; Moskovitz B; Nativ O
    Br J Urol; 1998 Nov; 82(5):647-54. PubMed ID: 9839578
    [No Abstract]   [Full Text] [Related]  

  • 44. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
    Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
    Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
    [No Abstract]   [Full Text] [Related]  

  • 45. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder.
    Young AK; Hammond E; Middleton AW
    J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL; Delahunt B; Bethwaite PB; Thornton A
    Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma.
    Guinan P; John T; Sadoughi N; Ablin RJ; Bush I
    J Urol; 1974 Mar; 111(3):350-2. PubMed ID: 4813575
    [No Abstract]   [Full Text] [Related]  

  • 48. Expression of squamous cell carcinoma-associated antigen in grade 3 pT1 transitional cell carcinoma of the bladder and prediction of its progression and intravesical recurrence.
    Yamazaki K; Kumamoto Y; Tsukamoto T
    Cancer; 1993 Dec; 72(12):3676-84. PubMed ID: 7902777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous antibodies to human bladder cancer.
    Grossman HB; Wedemeyer G; Stein J
    Cancer Immunol Immunother; 1988; 26(3):269-72. PubMed ID: 3383207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma.
    Sadoughi N; Mlsna J; Guinan P; Rubenstone A
    Urology; 1982 Aug; 20(2):143-6. PubMed ID: 7051508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
    Huland E; Arndt R; Huland H
    Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
    Yamada T; Fukui I; Yokogawa M; Oshima H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T; Yagita H; Hashimoto Y
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
    Masuko T; Abe J; Yagita H; Hashimoto Y
    Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demonstration and preliminary characterization of an antigen in the insoluble extracts of human transitional cell carcinoma.
    Okada S; Kurata Y; Kitagawa K; Ookawa M
    Eur J Cancer (1965); 1980 Nov; 16(11):1451-8. PubMed ID: 6785091
    [No Abstract]   [Full Text] [Related]  

  • 58. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells.
    Arndt R; Dürkopf H; Huland H; Donn F; Loening T; Kalthoff H
    J Urol; 1987 Apr; 137(4):758-63. PubMed ID: 3550155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A monoclonal antibody to human transitional-cell carcinoma of the bladder cross-reacting with a differentiation antigen of neutrophilic lineage.
    Baricordi OR; Sensi A; De Vinci C; Melchiorri L; Fabris G; Marchetti E; Corrado F; Mattiuz PL; Pizza G
    Int J Cancer; 1985 Jun; 35(6):781-6. PubMed ID: 3891639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.